Jubilee Syringe Manufacturing Limited (JSM) refutes recent media claims suggesting an end to its operations in Nigeria.
Despite facing challenges in meeting set targets, the company clarifies that it is undergoing a strategic restructuring phase, ensuring a stronger commitment to its Nigerian operations.
Since its inauguration in 2017, JSM has been a market leader, providing top-quality syringes and generating employment opportunities in Akwa Ibom State.
Acknowledging a need for improvement, the investors, led by the Managing Director of VKS Group of Companies, Mr. Onur Kumral, have decided to reorganize the management team and production structures for enhanced profitability and sustainability.
Contrary to reports, JSM assures its customers and the Nigerian public that the restructuring is a temporary measure. The shake-up primarily affects management staff and production lines, aiming to streamline operations and meet expected targets more effectively.
The Managing Director emphasizes that JSM is committed to its customers, assuring them of the company’s continued presence and dedication to producing the highest quality syringes in Nigeria.
Kumral urges the public to disregard rumors of a complete shutdown, emphasizing that JSM is implementing these measures to ensure its long-term success.
The company remains confident in its ability to overcome challenges, return to full operations soon, and contribute to the healthcare sector in Nigeria.
